Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
12.50
-0.33 (-2.57%)
At close: Oct 1, 2026, 4:00 PM EDT
12.53
+0.03 (0.24%)
Pre-market: Oct 2, 2026, 6:05 AM EDT
Ginkgo Bioworks Holdings Market Cap
Ginkgo Bioworks Holdings has a market cap or net worth of $841.75 million as of October 1, 2026. Its market cap has increased by 4.16% in one year.
Market Cap
841.75M
Enterprise Value
943.70M
1-Year Change
4.16%
Ranking
Category
Stock Price
$12.50
ChartMarket Cap Chart
Since April 19, 2021, Ginkgo Bioworks Holdings's market cap has decreased from $2.18B to $841.75M, a decrease of -61.43%. That is a compound annual growth rate of -16.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 841.75M | 78.22% |
| Dec 31, 2025 | 472.31M | -9.39% |
| Dec 31, 2024 | 521.27M | -84.36% |
| Dec 29, 2023 | 3.33B | 16.75% |
| Dec 30, 2022 | 2.86B | -76.89% |
| Dec 31, 2021 | 12.35B | 466.18% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alumis | 947.47M |
| Apnimed | 910.05M |
| Rigel Pharmaceuticals | 908.03M |
| Cybin | 907.41M |
| Jade Biosciences | 904.99M |
| Sana Biotechnology | 878.62M |
| SpyGlass Pharma | 866.97M |
| Ardelyx | 853.47M |